XPOVIO (selinexor) for the Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
XPOVIO is available as 60mg oral tablets. Credit: Karyopharm Therapeutics Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more